We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+11.67%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$770M
AUM Growth
+$80.6M
Cap. Flow
+$7.39M
Cap. Flow %
0.96%
Top 10 Hldgs %
29.27%
Holding
119
New
8
Increased
35
Reduced
57
Closed
3

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$5.19M
2
RTX icon
RTX Corp
RTX
+$988K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$945K
4
BA icon
Boeing
BA
+$923K
5
MRK icon
Merck
MRK
+$827K

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$878K
2
WBA
Walgreens Boots Alliance
WBA
+$712K
3
COST icon
Costco
COST
+$699K
4
QCOM icon
Qualcomm
QCOM
+$618K
5
AAPL icon
Apple
AAPL
+$607K

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 18.22%
3 Industrials 14.89%
4 Consumer Discretionary 12.6%
5 Communication Services 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUM icon
51
Yum! Brands
YUM
$41.8B
$6.58M 0.86%
60,650
+108
+0.2% +$11K
EA icon
52
Electronic Arts
EA
$53B
$6.55M 0.85%
45,630
+3,853
+9% +$497K
CMI icon
53
Cummins
CMI
$87.5B
$6.3M 0.82%
27,739
-117
-0.4% -$26.3K
PG icon
54
Procter & Gamble
PG
$336B
$6.25M 0.81%
44,891
-1,865
-4% -$261K
GSK icon
55
GSK
GSK
$104B
$6.02M 0.78%
130,938
+15,836
+14% +$727K
NVDA icon
56
NVIDIA
NVDA
$4.86T
$5.73M 0.74%
438,880
-11,880
-3% -$159K
LH icon
57
Labcorp
LH
$25B
$5.61M 0.73%
32,095
-61
-0.2% -$10.5K
ZBH icon
58
Zimmer Biomet
ZBH
$18.2B
$5.37M 0.7%
35,879
-15
-0% -$2.12K
LLY icon
59
Eli Lilly
LLY
$1.02T
$5.35M 0.7%
31,711
+815
+3% +$122K
REGN icon
60
Regeneron Pharmaceuticals
REGN
$78.5B
$5.25M 0.68%
10,858
+1,750
+19% +$945K
EBAY icon
61
eBay
EBAY
$50.6B
$5.11M 0.66%
+101,662
New +$5.19M
AXP icon
62
American Express
AXP
$227B
$4.97M 0.65%
41,105
+75
+0.2% +$8.31K
MDT icon
63
Medtronic
MDT
$109B
$4.94M 0.64%
42,214
-115
-0.3% -$12.7K
BUD icon
64
AB InBev
BUD
$170B
$4.52M 0.59%
64,671
-3,720
-5% -$235K
INTU icon
65
Intuit
INTU
$86.5B
$4.34M 0.56%
11,420
-280
-2% -$98.3K
HUBB icon
66
Hubbell
HUBB
$25B
$3.98M 0.52%
25,415
-150
-0.6% -$23K
DT
67
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$3.85M 0.5%
210,496
+8,025
+4% +$147K
MDLZ icon
68
Mondelez International
MDLZ
$79.5B
$3.78M 0.49%
64,634
-100
-0.2% -$5.71K
BAX icon
69
Baxter International
BAX
$13.5B
$3.62M 0.47%
45,082
+2,458
+6% +$195K
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.25M 0.42%
13,995
-275
-2% -$60.6K
TGT icon
71
Target
TGT
$65.6B
$2.77M 0.36%
15,700
-755
-5% -$126K
CVX icon
72
Chevron
CVX
$392B
$2.76M 0.36%
32,728
-2,645
-7% -$214K
NXPI icon
73
NXP Semiconductors
NXPI
$57.8B
$2.64M 0.34%
16,600
-49
-0.3% -$7.22K
EMR icon
74
Emerson Electric
EMR
$83.9B
$2.54M 0.33%
31,676
-385
-1% -$28.6K
SNA icon
75
Snap-on
SNA
$21.2B
$2.53M 0.33%
14,805
-380
-3% -$63.5K

Similar funds

Jacobs & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Jacobs & Co held 119 positions worth $770M, up 12% from $689M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Jacobs & Co's Q4 2020 filing shows 8 new, 35 increased, 57 reduced and 3 closed positions. Its largest new stake was eBay: 101,662 shares worth $5.11M. The largest sale was Raytheon Company, an estimated $878K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2020 buy was eBay: 101,662 shares worth $5.11M.
  • Jacobs & Co added most to Regeneron Pharmaceuticals in Q4 2020, an estimated $945K increase.
  • Jacobs & Co's biggest Q4 2020 reduction was Walgreens Boots Alliance, cutting an estimated $712K.
  • Jacobs & Co fully exited Raytheon Company in Q4 2020, selling an estimated $878K.
  • Jacobs & Co's ten largest holdings make up 29% of its $770M portfolio in Q4 2020.
  • Jacobs & Co opened 8 new positions and closed 3 in Q4 2020.
  • Jacobs & Co's portfolio value rose 12% quarter-over-quarter to $770M.

Based on Jacobs & Co's 13F filing for Q4 2020, filed 12 Jan 2021.